Note: Ingredients listed on restricted chemical lists
EC/CAS
200-683-7/68-26-8
Name of the chemical
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol (45)
Concentration
=1-<2,5
EC/CAS
200-014-9/50-14-6
Name of the chemical
Ergocalciferol (INN) and cholecalciferol (vitamins D2 and D3)
Concentration
>=1-<10
EC/CAS
203-838-7/111-14-8
Name of the chemical
Heptanoic acid
Concentration
>=1-<3%
EC/CAS
204-677-5/124-07-2
Name of the chemical
Octanoic acid
Concentration
=1-<2,5
EC/CAS
206-765-9/373-49-9
Name of the chemical
palmitoleic acid
Concentration
=1-<2,5
EC/CAS
202-051-6/91-22-5
Name of the chemical
Quinoline
Concentration
=1-<2,5
EC/CAS
201-228-5/79-81-2
Name of the chemical
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate (45)
Concentration
=1-<2,5
EC/CAS
206-376-4/334-48-5
Name of the chemical
Decanoic acid
Concentration
=1-<2,5 607-709-
EC/CAS
204-011-3/112-86-7
Name of the chemical
erucic acid
Concentration
>=1-<10
EC/CAS
205-582-1/143-07-7
Name of the chemical
lauric acid
Concentration
>=1-<3%
EC/CAS
206-129-0/302-79-4
Name of the chemical
Tretinoin (INN) (retinoic acid and its salts)
Concentration
=1-<2,5
EC/CAS
204-211-0/117-81-7
Name of the chemical
Bis(2-ethylhexyl)phthalat DEHP
Concentration
>=1-<10
General Information
Version
6.14
Revision date
2023-09-10
Product name
LSMLS Plate 7 (Lipophilic)
REACH No
This
Emergency telephone
+49 (0)696 43508409
Icons in SDS
Company Information
company name
Sigma-Aldrich Chemie GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
technischerservice@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318, H332, H341, H350, H360FD, H362, H373, H400, H410
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H318 Causes serious eye damage. H332 Harmful if inhaled. H341 Suspected of causing genetic defects. H350 May cause cancer. H360FD May damage fertility. May damage the unborn child. H362 May cause harm to breast-fed children. H373 May cause damage to organs through prolonged or repeated exposure if swallowed. H410 Very toxic to aquatic life with long lasting effects. Restricted to professional users. Reduced Labeling (<= 125 ml) H317 May cause an allergic skin reaction. H341 Suspected of causing genetic defects. H350 May cause cancer. H362 May cause harm to breast-fed children. H318 Causes serious eye damage. H360FD May damage fertility. May damage the unborn child.
Precautionary statements
P263 Avoid contact during pregnancy and while nursing. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
This substance/mixture contains components considered to have endocrine disrupting properties for environment , according to REACH Article 57(f), Commission Regulation (EU) 2018/605 or Commission Delegated Regulation (EU) 2017/2100.
TOXICOLOGICAL INFORMATION
This substance/mixture contains components considered to have endocrine disrupting properties affecting human health, according to REACH Article 57(f), Commission Regulation (EU) 2018/605 or Commission Delegated Regulation (EU) 2017/2100. Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials.
